Vanguard Group
YCBD icon

Vanguard Group’s cbdMD YCBD Stock Holding History

Vanguard Group’s Portfolio YCBD Stock Details YCBD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$133K Buy
98,210
+46,647
+90% +$47K ﹤0.01% 4142
2025
Q3 		$62.4K Buy
+51,563
New +$42.3K ﹤0.01% 4273
2025
Q2 		– Sell
-1,630
Closed -$3K – 4330
2025
Q1 		$3K Hold
1,630
– – ﹤0.01% 4277
2024
Q4 		$4.89K Hold
1,630
– – ﹤0.01% 4288
2024
Q3 		$6.13K Hold
1,630
– – ﹤0.01% 4334
2024
Q2 		$7.7K Hold
1,630
– – ﹤0.01% 4399
2024
Q1 		$12.1K Hold
1,630
– – ﹤0.01% 4415
2023
Q4 		$13.6K Hold
1,630
– – ﹤0.01% 4466
2023
Q3 		$13.5K Sell
1,630
-45
-3% -$461 ﹤0.01% 4513
2023
Q2 		$18.8K Sell
1,675
-2,047
-55% -$53.7K ﹤0.01% 4520
2023
Q1 		$261K Buy
3,722
+95
+3% +$8.81K ﹤0.01% 4277
2022
Q4 		$296K Buy
3,627
+3
+0.1% +$302 ﹤0.01% 4226
2022
Q3 		$294K Buy
3,624
+386
+12% +$55.4K ﹤0.01% 4349
2022
Q2 		$513K Sell
3,238
-20
-0.6% -$4.74K ﹤0.01% 4287
2022
Q1 		$1.22M Sell
3,258
-876
-21% -$296K ﹤0.01% 4149
2021
Q4 		$1.61M Sell
4,134
-23
-0.6% -$13.4K ﹤0.01% 4119
2021
Q3 		$3.11M Hold
4,157
– – ﹤0.01% 3901
2021
Q2 		$4.34M Buy
4,157
+526
+14% +$629K ﹤0.01% 3667
2021
Q1 		$5.41M Buy
3,631
+176
+5% +$256K ﹤0.01% 3490
2020
Q4 		$3.67M Buy
3,455
+26
+0.8% +$23.6K ﹤0.01% 3490
2020
Q3 		$2.47M Buy
3,429
+29
+0.9% +$27.7K ﹤0.01% 3429
2020
Q2 		$2.34M Sell
3,400
-220
-6% -$98.7K ﹤0.01% 3389
2020
Q1 		$1.21M Buy
3,620
+1,993
+122% +$786K ﹤0.01% 3440
2019
Q4 		$1.32M Buy
1,627
+21
+1% +$25.2K ﹤0.01% 3562
2019
Q3 		$2.29M Buy
1,606
+111
+7% +$178K ﹤0.01% 3409
2019
Q2 		$3.17M Buy
1,495
+439
+42% +$891K ﹤0.01% 3325
2019
Q1 		$1.68M Buy
1,056
+81
+8% +$127K ﹤0.01% 3505
2018
Q4 		$1.08M Buy
975
+306
+46% +$436K ﹤0.01% 3548
2018
Q3 		$874K Buy
+669
New +$848K ﹤0.01% 3751

Other funds holding YCBD

WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return
CD
Chapin Davis Baltimore, Maryland $569M AUM 145.59% 1-Year Est. Return
AA
Alesco Advisors Pittsford, New York $3.92B AUM 15.21% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
SG
StoneX Group New York $1.86B AUM 21.3% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Vanguard Group's YCBD Position: Q4 2025 in Review

Vanguard Group increased its cbdMD (YCBD) stake by 90% in Q4 2025, buying an estimated $47K and bringing the position to 98,210 shares worth $133K. The position accounts for ﹤0.01% of the portfolio, ranked #4142.

Vanguard Group first reported a position in YCBD in Q3 2018 and has held it in 29 quarters since. The position peaked at $5.41M in Q1 2021. 25 funds tracked by Wall St. Rank hold YCBD as of Q4 2025.

  • Vanguard Group held 98,210 shares of cbdMD worth $133K as of Q4 2025.
  • Vanguard Group bought 46,647 cbdMD shares in Q4 2025, an estimated $47K.
  • cbdMD made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #4142 holding.
  • Vanguard Group first reported a position in cbdMD in Q3 2018 and has held it in 29 quarters since.
  • Vanguard Group's cbdMD position peaked at $5.41M in Q1 2021.
  • 25 funds tracked by Wall St. Rank held cbdMD as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.